233 related articles for article (PubMed ID: 1773786)
1. Genetic studies on lung tumor susceptibility and histogenesis in mice.
Malkinson AM
Environ Health Perspect; 1991 Jun; 93():149-59. PubMed ID: 1773786
[TBL] [Abstract][Full Text] [Related]
2. Effects of strain and age on prophylaxis and co-carcinogenesis of urethan-induced mouse lung adenomas by butylated hydroxytoluene.
Malkinson AM; Thaete LG
Cancer Res; 1986 Apr; 46(4 Pt 1):1694-7. PubMed ID: 3948160
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation.
Malkinson AM; Beer DS
J Natl Cancer Inst; 1984 Oct; 73(4):925-33. PubMed ID: 6592388
[TBL] [Abstract][Full Text] [Related]
4. Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain.
Miller AC; Dwyer LD; Auerbach CE; Miley FB; Dinsdale D; Malkinson AM
Toxicology; 1994 May; 90(1-2):141-59. PubMed ID: 8023339
[TBL] [Abstract][Full Text] [Related]
5. A metabolite of butylated hydroxytoluene with potent tumor-promoting activity in mouse lung.
Thompson JA; Schullek KM; Fernandez CA; Malkinson AM
Carcinogenesis; 1989 Apr; 10(4):773-5. PubMed ID: 2702725
[TBL] [Abstract][Full Text] [Related]
6. Separation of early diffuse alveolar cell proliferation from enhanced tumor development in mouse lung.
Witschi HP
Cancer Res; 1986 Jun; 46(6):2675-9. PubMed ID: 3698002
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to urethane carcinogenesis of transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) and its modification by butylhydroxytoluene.
Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y
Cancer Lett; 1999 Oct; 145(1-2):101-6. PubMed ID: 10530776
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the metabolism of butylated hydroxytoluene (BHT) and lung tumor promotion in mice.
Thompson JA; Bolton JL; Malkinson AM
Exp Lung Res; 1991; 17(2):439-53. PubMed ID: 2050043
[TBL] [Abstract][Full Text] [Related]
9. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.
Lin L; Festing MF; Devereux TR; Crist KA; Christiansen SC; Wang Y; Yang A; Svenson K; Paigen B; Malkinson AM; You M
Exp Lung Res; 1998; 24(4):481-97. PubMed ID: 9659579
[TBL] [Abstract][Full Text] [Related]
10. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene.
Gressani KM; Leone-Kabler S; O'Sullivan MG; Case LD; Malkinson AM; Miller MS
Carcinogenesis; 1999 Nov; 20(11):2159-65. PubMed ID: 10545420
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters.
Miller MS; Gressani KM; Leone-Kabler S; Townsend AJ; Malkinson AM; O'Sullivan MG
Exp Lung Res; 2000 Dec; 26(8):709-30. PubMed ID: 11195466
[TBL] [Abstract][Full Text] [Related]
12. Decrease in the protein kinase C-catalyzed phosphorylation of an endogenous lung protein (Mr 36,000) following treatment of mice with the tumor-modulatory agent butylated hydroxytoluene.
Malkinson AM; Beer DS; Sadler AJ; Coffman DS
Cancer Res; 1985 Nov; 45(11 Pt 2):5751-6. PubMed ID: 4053047
[TBL] [Abstract][Full Text] [Related]
13. Lung adenoma structure among inbred strains of mice: the pulmonary adenoma histologic type (Pah) genes.
Thaete LG; Nesbitt MN; Malkinson AM
Cancer Lett; 1991 Dec; 61(1):15-20. PubMed ID: 1764694
[TBL] [Abstract][Full Text] [Related]
14. Genetic influence on type 2 or Clara cell origin of pulmonary adenomas in urethan-treated mice.
Beer DG; Malkinson AM
J Natl Cancer Inst; 1985 Nov; 75(5):963-9. PubMed ID: 3863993
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene.
Witschi H; Williamson D; Lock S
J Natl Cancer Inst; 1977 Feb; 58(2):301-5. PubMed ID: 833878
[TBL] [Abstract][Full Text] [Related]
16. Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene.
Malkinson AM; Koski KM; Evans WA; Festing MF
Cancer Res; 1997 Jul; 57(14):2832-4. PubMed ID: 9230183
[TBL] [Abstract][Full Text] [Related]
17. Studies using structural analogs and inbred strain differences to support a role for quinone methide metabolites of butylated hydroxytoluene (BHT) in mouse lung tumor promotion.
Thompson JA; Carlson TJ; Sun Y; Dwyer-Nield LD; Malkinson AM
Toxicology; 2001 Mar; 160(1-3):197-205. PubMed ID: 11246140
[TBL] [Abstract][Full Text] [Related]
18. Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert-butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion.
Dwyer-Nield LD; Thompson JA; Peljak G; Squier MK; Barker TD; Parkinson A; Cohen JJ; Dinsdale D; Malkinson AM
Toxicology; 1998 Sep; 130(2-3):115-27. PubMed ID: 9865479
[TBL] [Abstract][Full Text] [Related]
19. Promotion of lung tumors in mice.
Witschi HP
Environ Health Perspect; 1983 Apr; 50():267-73. PubMed ID: 6873018
[TBL] [Abstract][Full Text] [Related]
20. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice.
Malkinson AM; Radcliffe RA; Bauer AK
Carcinogenesis; 2002 Mar; 23(3):411-7. PubMed ID: 11895855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
